In this report, our team research the global Chemotherapy-induced Nausea and Vomiting (CINV) market by type, application, region and manufacturer 2013-2018 and forcast 2019-2024. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Chemotherapy-induced Nausea and Vomiting (CINV) in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Chemotherapy-induced Nausea and Vomiting (CINV) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
GlaxoSmithKline
Helsinn Holding
Heron Therapeutics
Merck & Co., Inc
Tesaro, Inc
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Aloxi, Kytril
Emend
Netupitant-Palonosetron
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Chemotherapy-induced Nausea and Vomiting (CINV) for each application, including
Hospital
Research Institute
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Chemotherapy-induced Nausea and Vomiting (CINV) Market by Manufacturers, Regions, Type and Application, Forecast to 2023
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Chemotherapy-induced Nausea and Vomiting (CINV) Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Product Type Market
2.1 World Product Type Market Performance and Trend
2.1.1 World Market Performance
2.1.2 Different Type of Market Performance
2.2 North America Product Type Market Performance and Trend
2.2.1 North America Market Performance
2.2.2 Different Type of Market Performance
2.3 Europe Product Type Market Performance and Trend
2.3.1 Europe Market Performance
2.3.2 Different Type of Market Performance
2.4 Asia-Pacific Product Type Market Performance and Trend
2.4.1 Asia-Pacific Market Performance
2.4.2 Different Type of Market Performance
2.5 South America Product Type Market Performance and Trend
2.5.1 South America Market Performance
2.5.2 Different Type of Market Performance
2.6 Middle East and Africa Product Type Market Performance and Trend
2.6.1 Middle East and Africa Market Performance
2.6.2 Different Type of Market Performance
3 Product Application Market
3.1 World Product Application Market Performance and Trend
3.1.1 World Market Performance
3.1.2 Different Applications of Market Trend
3.2 North America Product Application Market Performance and Trend
3.2.1 North America Market Performance
3.2.2 Different Applications of Market Trend
3.3 Europe Product Application Market Performance and Trend
3.3.1 Europe Market Performance
3.3.2 Different Applications of Market Trend
3.4 Asia-Pacific Product Application Market Performance and Trend
3.4.1 Asia-Pacific Market Performance
3.4.2 Different Applications of Market Trend
3.5 South America Product Application Market Performance and Trend
3.5.1 South America Market Performance
3.5.2 Different Applications of Market Trend
3.6 Middle East and Africa Product Application Market Performance and Trend
3.6.1 Middle East and Africa Market Performance
3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
4.1 GlaxoSmithKline
4.1.1 GlaxoSmithKline Profiles
4.1.2 GlaxoSmithKline Product Information
4.1.3 GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting (CINV) Business Performance
4.1.4 GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting (CINV) Business Development and Market Status
4.2 Helsinn Holding
4.2.1 Helsinn Holding Profiles
4.2.2 Helsinn Holding Product Information
4.2.3 Helsinn Holding Chemotherapy-induced Nausea and Vomiting (CINV) Business Performance
4.2.4 Helsinn Holding Chemotherapy-induced Nausea and Vomiting (CINV) Business Development and Market Status
4.3 Heron Therapeutics
4.3.1 Heron Therapeutics Profiles
4.3.2 Heron Therapeutics Product Information
4.3.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting (CINV) Business Performance
4.3.4 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting (CINV) Business Development and Market Status
4.4 Merck & Co., Inc
4.4.1 Merck & Co., Inc Profiles
4.4.2 Merck & Co., Inc Product Information
4.4.3 Merck & Co., Inc Chemotherapy-induced Nausea and Vomiting (CINV) Business Performance
4.4.4 Merck & Co., Inc Chemotherapy-induced Nausea and Vomiting (CINV) Business Development and Market Status
4.5 Tesaro, Inc
4.5.1 Tesaro, Inc Profiles
4.5.2 Tesaro, Inc Product Information
4.5.3 Tesaro, Inc Chemotherapy-induced Nausea and Vomiting (CINV) Business Performance
4.5.4 Tesaro, Inc Chemotherapy-induced Nausea and Vomiting (CINV) Business Development and Market Status
6.1.1 Published Date: Jun. 2019 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share of Manufacturers 2013-2019
5 Market Performance for Manufacturers
5.1 Global Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Market Share by Manufacturers 2013-2018
5.2 Global Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Market Share by Manufacturers 2013-2018
5.3 Global Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
5.4 Global Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 North America Market Performance for Manufacturers
6.1.1 North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share of Manufacturers 2013-2018
6.1.2 North America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share of Manufacturers 2013-2018
6.1.3 North America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
6.1.4 North America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
6.1.5 Market Concentration
6.2 Europe Market Performance for Manufacturers
6.2.1 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share of Manufacturers 2013-2018
6.2.2 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share of Manufacturers 2013-2018
6.2.3 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
6.2.4 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
6.2.5 Market Concentration
6.3 Asia-Pacific Market Performance for Manufacturers
6.3.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share of Manufacturers 2013-2018
6.3.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share of Manufacturers 2013-2018
6.3.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
6.3.4 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
6.3.5 Market Concentration
6.4 South America Market Performance for Manufacturers
6.4.1 South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share of Manufacturers 2013-2018
6.4.2 South America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share of Manufacturers 2013-2018
6.4.3 South America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
6.4.4 South America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
6.4.5 Market Concentration
6.5 Middle East and Africa Market Performance for Manufacturers
6.5.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share of Manufacturers 2013-2018
6.5.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share of Manufacturers 2013-2018
6.5.3 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
6.5.4 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
6.5.5 Market Concentration
7 World Market Performance Point
7.1 World Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share by Regions and Countries 2013-2018
7.1.1 World Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share by Regions 2013-2018
7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018
7.1.2.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share by Countries 2013-2018
7.1.2.2 North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share by Countries 2013-2018
7.1.2.3 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share by Countries 2013-2018
7.1.2.4 South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share by Countries 2013-2018
7.1.2.5 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Share by Countries 2013-2018
7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018
7.2.1 World Revenue (M USD) and Share by Regions 2013-2018
7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018
7.2.2.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share by Countries 2013-2018
7.2.2.2 North America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share by Countries 2013-2018
7.2.2.3 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share by Countries 2013-2018
7.2.2.4 South America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share by Countries 2013-2018
7.2.2.5 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) and Share by Countries 2013-2018
7.3 World Price (USD/Unit) by Regions and Countries 2013-2018
7.3.1 World Price (USD/Unit) by Regions 2013-2018
7.3.2 Regional Price (USD/Unit) by Countries 2013-2018
7.3.2.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) by Countries 2013-2018
7.3.2.2 North America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) by Countries 2013-2018
7.3.2.3 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) by Countries 2013-2018
7.3.2.4 South America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) by Countries 2013-2018
7.3.2.5 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) by Countries 2013-2018
7.4 World Gross Margin by Regions and Countries 2013-2018
7.4.1 World Gross Margin by Regions 2013-2018
7.4.2 Regional Gross Margin and Share by Countries 2013-2018
7.4.2.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin and Share by Countries 2013-2018
7.4.2.2 North America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin and Share by Countries 2013-2018
7.4.2.3 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin and Share by Countries 2013-2018
7.4.2.4 South America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin and Share by Countries 2013-2018
7.4.2.5 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin and Share by Countries 2013-2018
8 Development Trend for Regions and Countries (Sales Point)
8.1 World Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3 North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5 South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Hospital Industry
11.2 Research Institute Industry
12 Market Forecast 2019-2024
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
12.1.1 Global Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
12.1.2 Global Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) and Growth Rate 2019-2024
12.1.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.4 Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.5 Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.6 South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.7 Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024
12.2.1 Overall Market Performance
12.2.2 Aloxi, Kytril Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.3 Emend Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.4 Netupitant-Palonosetron Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3 Sales by Application 2019-2024
12.3.1 Overall Market Performance
12.3.2 Hospital Sales and and Growth Rate 2019-2024
12.3.3 Research Institute Sales and and Growth Rate 2019-2024
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) Trend 2019-2024
12.4.2 Global Chemotherapy-induced Nausea and Vomiting (CINV) Gross Profit Trend 2019-2024
13 Conclusion
List of Tables and Figures
Figure Product Picture of Chemotherapy-induced Nausea and Vomiting (CINV)
Table Product Specifications of Chemotherapy-induced Nausea and Vomiting (CINV)
Table Manufacturers List in the Report
Table Manufacturers Market Share 2013-2018
Table Regions Overview in the Report
Table Product Type and Standard
Table Type Overview
Table Product Application and Standard
Table Application Overview in the Report
Figure Industry Chain Structure of Chemotherapy-induced Nausea and Vomiting (CINV)
Table Industry News List of Chemotherapy-induced Nausea and Vomiting (CINV)
Figure New Project SWOT Analysis of Chemotherapy-induced Nausea and Vomiting (CINV)
Table World 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Type
Figure World Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2013
Figure World Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2018
Table World 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV)Revenue (M USD) by Type
Figure World Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2013
Figure World Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2018
Table World Aloxi, Kytril Sales (K Units) and Growth Rate
Figure World Aloxi, Kytril Sales (K Units) and Growth Rate
Table World Aloxi, Kytril Revenue (M USD) and Growth Rate
Figure World Aloxi, Kytril Revenue (M USD) and Growth Rate
Table World Emend Sales (K Units) and Growth Rate
Figure World Emend Sales (K Units) and Growth Rate
Table World Emend Revenue (M USD) and Growth Rate
Figure World Emend Revenue (M USD) and Growth Rate
Table World Netupitant-Palonosetron Sales (K Units) and Growth Rate
Figure World Netupitant-Palonosetron Sales (K Units) and Growth Rate
Table World Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Figure World Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Table World Others Sales (K Units) and Growth Rate
Figure World Others Sales (K Units) and Growth Rate
Table World Others Revenue (M USD) and Growth Rate
Figure World Others Revenue (M USD) and Growth Rate
Table North America 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Type
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2018
Table North America 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV)Revenue (M USD) by Type
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Market Share (%) by Type in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Market Share (%) by Type in 2018
Table North America Aloxi, Kytril Sales (K Units) and Growth Rate
Figure North America Aloxi, Kytril Sales (K Units) and Growth Rate
Table North America Aloxi, Kytril Revenue (M USD) and Growth Rate
Figure North America Aloxi, Kytril Revenue (M USD) and Growth Rate
Table North America Emend Sales (K Units) and Growth Rate
Figure North America Emend Sales (K Units) and Growth Rate
Table North America Emend Revenue (M USD) and Growth Rate
Figure North America Emend Revenue (M USD) and Growth Rate
Table North America Netupitant-Palonosetron Sales (K Units) and Growth Rate
Figure North America Netupitant-Palonosetron Sales (K Units) and Growth Rate
Table North America Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Figure North America Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Table North America Others Sales (K Units) and Growth Rate
Figure North America Others Sales (K Units) and Growth Rate
Table North America Others Revenue (M USD) and Growth Rate
Figure North America Others Revenue (M USD) and Growth Rate
Table Europe 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Type
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2013
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2018
Table Europe 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV)Revenue (M USD) by Type
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2013
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2018
Table Europe Aloxi, Kytril Sales (K Units) and Growth Rate
Figure Europe Aloxi, Kytril Sales (K Units) and Growth Rate
Table Europe Aloxi, Kytril Revenue (M USD) and Growth Rate
Figure Europe Aloxi, Kytril Revenue (M USD) and Growth Rate
Table Europe Emend Sales (K Units) and Growth Rate
Figure Europe Emend Sales (K Units) and Growth Rate
Table Europe Emend Revenue (M USD) and Growth Rate
Figure Europe Emend Revenue (M USD) and Growth Rate
Table Europe Netupitant-Palonosetron Sales (K Units) and Growth Rate
Figure Europe Netupitant-Palonosetron Sales (K Units) and Growth Rate
Table Europe Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Figure Europe Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Table Europe Others Sales (K Units) and Growth Rate
Figure Europe Others Sales (K Units) and Growth Rate
Table Europe Others Revenue (M USD) and Growth Rate
Figure Europe Others Revenue (M USD) and Growth Rate
Table Asia-Pacific 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Type
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2013
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2018
Table Asia-Pacific 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV)Revenue (M USD) by Type
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2013
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2018
Table Asia-Pacific Aloxi, Kytril Sales (K Units) and Growth Rate
Figure Asia-Pacific Aloxi, Kytril Sales (K Units) and Growth Rate
Table Asia-Pacific Aloxi, Kytril Revenue (M USD) and Growth Rate
Figure Asia-Pacific Aloxi, Kytril Revenue (M USD) and Growth Rate
Table Asia-Pacific Emend Sales (K Units) and Growth Rate
Figure Asia-Pacific Emend Sales (K Units) and Growth Rate
Table Asia-Pacific Emend Revenue (M USD) and Growth Rate
Figure Asia-Pacific Emend Revenue (M USD) and Growth Rate
Table Asia-Pacific Netupitant-Palonosetron Sales (K Units) and Growth Rate
Figure Asia-Pacific Netupitant-Palonosetron Sales (K Units) and Growth Rate
Table Asia-Pacific Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Figure Asia-Pacific Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Table Asia-Pacific Others Sales (K Units) and Growth Rate
Figure Asia-Pacific Others Sales (K Units) and Growth Rate
Table Asia-Pacific Others Revenue (M USD) and Growth Rate
Figure Asia-Pacific Others Revenue (M USD) and Growth Rate
Table South America 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Type
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2013
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2018
Table South America 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV)Revenue (M USD) by Type
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2013
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2018
Table South America Aloxi, Kytril Sales (K Units) and Growth Rate
Figure South America Aloxi, Kytril Sales (K Units) and Growth Rate
Table South America Aloxi, Kytril Revenue (M USD) and Growth Rate
Figure South America Aloxi, Kytril Revenue (M USD) and Growth Rate
Table South America Emend Sales (K Units) and Growth Rate
Figure South America Emend Sales (K Units) and Growth Rate
Table South America Emend Revenue (M USD) and Growth Rate
Figure South America Emend Revenue (M USD) and Growth Rate
Table South America Netupitant-Palonosetron Sales (K Units) and Growth Rate
Figure South America Netupitant-Palonosetron Sales (K Units) and Growth Rate
Table South America Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Figure South America Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Table South America Others Sales (K Units) and Growth Rate
Figure South America Others Sales (K Units) and Growth Rate
Table South America Others Revenue (M USD) and Growth Rate
Figure South America Others Revenue (M USD) and Growth Rate
Table Middle East and Africa 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Type
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2013
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Type in 2018
Table Middle East and Africa 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV)Revenue (M USD) by Type
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2013
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV)Revenue Market Share (%) by Type in 2018
Table Middle East and Africa Aloxi, Kytril Sales (K Units) and Growth Rate
Figure Middle East and Africa Aloxi, Kytril Sales (K Units) and Growth Rate
Table Middle East and Africa Aloxi, Kytril Revenue (M USD) and Growth Rate
Figure Middle East and Africa Aloxi, Kytril Revenue (M USD) and Growth Rate
Table Middle East and Africa Emend Sales (K Units) and Growth Rate
Figure Middle East and Africa Emend Sales (K Units) and Growth Rate
Table Middle East and Africa Emend Revenue (M USD) and Growth Rate
Figure Middle East and Africa Emend Revenue (M USD) and Growth Rate
Table Middle East and Africa Netupitant-Palonosetron Sales (K Units) and Growth Rate
Figure Middle East and Africa Netupitant-Palonosetron Sales (K Units) and Growth Rate
Table Middle East and Africa Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Figure Middle East and Africa Netupitant-Palonosetron Revenue (M USD) and Growth Rate
Table Middle East and Africa Others Sales (K Units) and Growth Rate
Figure Middle East and Africa Others Sales (K Units) and Growth Rate
Table Middle East and Africa Others Revenue (M USD) and Growth Rate
Figure Middle East and Africa Others Revenue (M USD) and Growth Rate
Table World 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Application
Figure World Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2013
Figure World Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2018
Table World Hospital Sales (K Units) and Growth Rate
Figure World Hospital Sales (K Units) and Growth Rate
Table World Research Institute Sales (K Units) and Growth Rate
Figure World Research Institute Sales (K Units) and Growth Rate
Table North America 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Application
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2018
Table North America Hospital Sales (K Units) and Growth Rate
Figure North America Hospital Sales (K Units) and Growth Rate
Table North America Research Institute Sales (K Units) and Growth Rate
Figure North America Research Institute Sales (K Units) and Growth Rate
Table Europe 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Application
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2013
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2018
Table Europe Hospital Sales (K Units) and Growth Rate
Figure Europe Hospital Sales (K Units) and Growth Rate
Table Europe Research Institute Sales (K Units) and Growth Rate
Figure Europe Research Institute Sales (K Units) and Growth Rate
Table Asia-Pacific 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Application
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2013
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2018
Table Asia-Pacific Hospital Sales (K Units) and Growth Rate
Figure Asia-Pacific Hospital Sales (K Units) and Growth Rate
Table Asia-Pacific Research Institute Sales (K Units) and Growth Rate
Figure Asia-Pacific Research Institute Sales (K Units) and Growth Rate
Table South America 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Application
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2013
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2018
Table South America Hospital Sales (K Units) and Growth Rate
Figure South America Hospital Sales (K Units) and Growth Rate
Table South America Research Institute Sales (K Units) and Growth Rate
Figure South America Research Institute Sales (K Units) and Growth Rate
Table Middle East and Africa 2013-2018 Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) by Application
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2013
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting (CINV) Sales Market Share (%) by Application in 2018
Table Middle East and Africa Hospital Sales (K Units) and Growth Rate
Figure Middle East and Africa Hospital Sales (K Units) and Growth Rate
Table Middle East and Africa Research Institute Sales (K Units) and Growth Rate
Figure Middle East and Africa Research Institute Sales (K Units) and Growth Rate
Table GlaxoSmithKline Profiles
Table GlaxoSmithKline Product Information
Table GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting (CINV) Sales Change 2013-2018
Table GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting (CINV) Market Status Change 2013-2018
Table Helsinn Holding Profiles
Table Helsinn Holding Product Information
Table Helsinn Holding Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Helsinn Holding Chemotherapy-induced Nausea and Vomiting (CINV) Sales Change 2013-2018
Table Helsinn Holding Chemotherapy-induced Nausea and Vomiting (CINV) Market Status Change 2013-2018
Table Heron Therapeutics Profiles
Table Heron Therapeutics Product Information
Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting (CINV) Sales Change 2013-2018
Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting (CINV) Market Status Change 2013-2018
Table Merck & Co., Inc Profiles
Table Merck & Co., Inc Product Information
Table Merck & Co., Inc Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Merck & Co., Inc Chemotherapy-induced Nausea and Vomiting (CINV) Sales Change 2013-2018
Table Merck & Co., Inc Chemotherapy-induced Nausea and Vomiting (CINV) Market Status Change 2013-2018
Table Tesaro, Inc Profiles
Table Tesaro, Inc Product Information
Table Tesaro, Inc Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Tesaro, Inc Chemotherapy-induced Nausea and Vomiting (CINV) Sales Change 2013-2018
Table Tesaro, Inc Chemotherapy-induced Nausea and Vomiting (CINV) Market Status Change 2013-2018
Table World Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) of Manufacturers 2013-2018
Table World Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share of Manufacturers 2013-2018
Figure World Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2013
Figure World Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2018
Table World Revenue (M USD) of Manufacturers 2013-2018
Table World Revenue Share of Manufacturers 2013-2018
Figure World Revenue Share in 2013
Figure World Revenue Share in 2018
Table World Price (USD/Unit) of Manufacturers 2013-2018
Figure World Price (USD/Unit) of Manufacturers in 2013
Figure World Price (USD/Unit) of Manufacturers in 2018
Table World Gross Margin of Manufacturers 2013-2018
Figure World Gross Margin of Manufacturers in 2013
Figure World Gross Margin in 2018
Figure World Market Concentration 2013-2018
Table Top 3 Sales Share 2013-2018
Table Top 5 Sales Share 2013-2018
Table Top 8 Sales Share 2013-2018
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) of Manufacturers 2013-2018
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share of Manufacturers 2013-2018
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2013
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2018
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) of Manufacturers 2013-2018
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share of Manufacturers 2013-2018
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share in 2013
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share in 2018
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers in 2013
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers in 2018
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers in 2013
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin in 2018
Figure Asia-Pacific Market Concentration 2013-2018
Table Top 3 Sales Share 2013-2018
Table Top 5 Sales Share 2013-2018
Table Top 8 Sales Share 2013-2018
Table North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) of Manufacturers 2013-2018
Table North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share of Manufacturers 2013-2018
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2018
Table North America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) of Manufacturers 2013-2018
Table North America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share of Manufacturers 2013-2018
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share in 2018
Table North America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers in 2018
Table North America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin in 2018
Figure North America Market Concentration 2013-2018
Table Top 3 Sales Share 2013-2018
Table Top 5 Sales Share 2013-2018
Table Top 8 Sales Share 2013-2018
Table Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) of Manufacturers 2013-2018
Table Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share of Manufacturers 2013-2018
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2013
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2018
Table Europe Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) of Manufacturers 2013-2018
Table Europe Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share of Manufacturers 2013-2018
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share in 2013
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share in 2018
Table Europe Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers in 2013
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers in 2018
Table Europe Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers in 2013
Figure Europe Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin in 2018
Figure Europe Market Concentration 2013-2018
Table Top 3 Sales Share 2013-2018
Table Top 5 Sales Share 2013-2018
Table Top 8 Sales Share 2013-2018
Table South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales (K Units) of Manufacturers 2013-2018
Table South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share of Manufacturers 2013-2018
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2013
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Sales Share in 2018
Table South America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue (M USD) of Manufacturers 2013-2018
Table South America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share of Manufacturers 2013-2018
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share in 2013
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Revenue Share in 2018
Table South America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers 2013-2018
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers in 2013
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Price (USD/Unit) of Manufacturers in 2018
Table South America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers 2013-2018
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin of Manufacturers in 2013
Figure South America Chemotherapy-induced Nausea and Vomiting (CINV) Gross Margin in 2018
Figure South America Market Concentration 2013-2018
Table Top 3 Sales Share 2013-2018
Table Top 5 Sales Share 2013-2018
Cross-segment Market Size and Analysis for
Mentioned Segments
